Clinical experience with the uterine progesterone system (Progestasert R).

No abstract is available for this paper.

• Publication year

  1976

• Venue

  Contraception

• Publication date

  1976-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0010-7824(76)90012-3PMID 1261259
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Safety and effectiveness of intrauterine devices.

  1975cited by this paper
• Endometrial morphology in women exposed to uterine systems releasing progesterone.

  1975cited by this paper
• The effect of intrauterine progesterone on the hypothalamic-hypophyseal-ovarian axis in humans.

  1975cited by this paper
• Clinical study of a progesterone-releasing intrauterine contraceptive device.

  1975cited by this paper
• Special requirements for hormone releasing intrauterine devices.

  1974cited by this paper
• Progestasert: a uterine therapeutic system for long-term contraception: I. Philosophy and clinical efficacy.

  1974cited by this paper
• Fertility Control by Intrauterine Release of Progesterone

  1974cited by this paper
• Copper IUDS: a review of the literature.

  1974cited by this paper
• Contraception through the use of intrauterine metals. I. Copper as an adjunct to the "T" device. The endouterine copper "T".

  1971cited by this paper
• Metallic copper as an intrauterine contraceptice adjunct to the "T" device.

  1969cited by this paper

• Women-specific routes of administration for drugs: a critical overview.

  2021cites this paper
• Controlled release for local delivery of drugs: barriers and models.

  2014cites this paper
• Cervical cancer treatment with a locally insertable controlled release delivery system.

  2006cites this paper
• 25 years of quinacrine sterilization experience in Chile: review of 2,592 cases

  2003cites this paper
• Progestin-Releasing Intrauterine Systems

  2001cites this paper
• Progestin-releasing intrauterine systems.

  2001cites this paper
• Controlled delivery of antibodies against leukocyte adhesion molecules from polymer matrices

  1996cites this paper
• Controlled release of antibodies for long-term topical passive immunoprotection of female mice against genital herpes

  1996cites this paper
• Controlled vaginal delivery of antibodies in the mouse.

  1992cites this paper
• Release kinetics of polymeric prodrugs of pindolol (PDL)

  1991cites this paper
• The Nova-T IUD--a review of the literature.

  1991cites this paper
• Consequences of uterine blood loss caused by various intrauterine contraceptive devices in South American women. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction.

  1988cites this paper
• Quantitative studies on menstrual blood loss in IUD users.

  1987cites this paper
• Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.

  1987cites this paper
• Sustained release of a corticosteroid using polymeric implants

  1986cites this paper
• Ultrastructure of the decidual response to a progesterone-releasing IUD

  1985cites this paper
• Effect of various oral contraceptive combinations on dysmenorrhea.

  1984cites this paper
• Treatment of menorrhagia with intrauterine release of progesterone

  1983cites this paper
• IUDs and ectopic pregnancy.

  1983cites this paper
• Implantable controlled release systems.

  1983cites this paper
• The effects of three different regimens of oral contraceptives and three different intrauterine devices on the levels of hemoglobin, serum iron and iron binding capacity in anemic women.

  1983cites this paper
• Will progesterone save the IUD?

  1983cites this paper
• Treatment of menorrhagia with intrauterine release of progesterone.

  1983cites this paper
• Lactation pattern in Egyptian women using the Progestasert system.

  1982cites this paper
• Physiologically active polymers and macromolecular therapeutic systems

  1982cites this paper
• Uterine geometry and IUCD design

  1982cites this paper
• Intrauterine contraception with levonorgestrel: a comparative randomised clinical performance study.

  1981cites this paper
• Present and future applications of biomaterials in controlled drug delivery systems.

  1981cites this paper
• INVITED REVIEW POLYMERIC DELIVERY SYSTEMS FOR CONTROLLED DRUG RELEASE

  1980cites this paper
• Selected events following insertion of the Progestasert system.

  1980cites this paper
• [A comparative study of the clinical effectiveness of Progestasert and Copper-T-200 (author's transl)].

  1980cites this paper
• Patterns of ovulation and bleeding with a low levonorgestrel-releasing intrauterine device.

  1980cites this paper
• Uterine Geometry and IUD Performance

  1980cites this paper
• Indications for Progesterone-Releasing IUDs

  1980cites this paper
• A COMPARATIVE STUDY OF THE EFFECT OF THE PROGESTASERTTM AND GRAVIGARD IDDS ON DYSMENORRHOEA

  1979cites this paper
• Differences in effect of copper and ProgestasertR IUDS on fibrinolytic activity of the endometrium in the rabbit.

  1979cites this paper
• Values of steroidal intrauterine contraception for developing countries.

  1979cites this paper
• Experience with two different medicated intrauterine devices: a comparative study of the Progestasert and Nova-T.

  1979cites this paper
• A comparative study of the effect of the Progestasert TM and Gravigard IUDs on dysmenorrhoea.

  1979cites this paper
• No increase of the fibrinolytic activity of the human endometrium by progesterone-releasing IUD (progestasertR).

  1978cites this paper
• Contraception with a norethisterone-releasing IUD. Plasma levels of norethisterone and its influence on the ovarian function.

  1978cites this paper
• A comparative study of the contraceptive mechanism of the Cu-intrauterine device and the plastic-intrauterine device in rats.

  1978cites this paper
• Clinical experience with the intrauterine progesterone contraceptive system.

  1978cites this paper
• Determination of plasma concentrations of d-norgestrel during a one year follow-up in women with a d-norgestrel-releasing IUD.

  1978cites this paper
• Effect of the Lippes IUD on the circulating levels of hemoglobin, hematocrit, serum iron and iron binding capacity in normal women.

  1978cites this paper
• Endometrial morphology of women using a d-norgestrel-releasing intrauterine device.

  1978cites this paper
• Factors that affect IUD performance: a review and recommendations.

  1978cites this paper
• Progesterone Retention by Rat Uterus I: Pharmacokinetics after Uterine Intraluminal Instillation

  1977cites this paper
• Progesterone metabolism by human proliferative and secretory endometria.

  1977cites this paper
• Comparative study of the Progesterone T (65 μg daily) and Copper 7 IUD

  1977cites this paper
• Clinical aspects of intrauterine contraception: circumspection 1976.

  1977cites this paper
• SUBCELLULAR DISTRIBUTION OF LYSOSOMAL ENZYMES IN THE HUMAN ENDOMETRIUM. II. EFFECT OF THE INERT, AND COPPER AND PROGESTERONE-RELEASING T INTRAUTERINE DEVICES*

  1977cites this paper
• Progesterone retention by rat uterus I. Pharmacokinetics after uterine intraluminal instillation.

  1977cites this paper
• An Overview of IUD Research and Implications for the Future

  1977cites this paper
• Comparative study of the progesterone t (65 microgram daily) and copper 7 iud.

  1977cites this paper
• Effects of the Progestasert on the menstrual pattern, ovarian steroids and endometrium.

  1977cites this paper
• Which I.U.D.?

  1977cites this paper
• Management and outcome of pregnancies associated with the Copper T intrauterine contraceptive device.

  1976cites this paper